1. Home
  2. AUPH vs JKS Comparison

AUPH vs JKS Comparison

Compare AUPH & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • JKS
  • Stock Information
  • Founded
  • AUPH 1993
  • JKS 2006
  • Country
  • AUPH Canada
  • JKS China
  • Employees
  • AUPH N/A
  • JKS N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • JKS Semiconductors
  • Sector
  • AUPH Health Care
  • JKS Technology
  • Exchange
  • AUPH Nasdaq
  • JKS Nasdaq
  • Market Cap
  • AUPH 1.4B
  • JKS 1.3B
  • IPO Year
  • AUPH 1999
  • JKS 2010
  • Fundamental
  • Price
  • AUPH $12.74
  • JKS $25.12
  • Analyst Decision
  • AUPH Strong Buy
  • JKS Sell
  • Analyst Count
  • AUPH 3
  • JKS 4
  • Target Price
  • AUPH $12.00
  • JKS $28.99
  • AVG Volume (30 Days)
  • AUPH 1.6M
  • JKS 553.7K
  • Earning Date
  • AUPH 11-06-2025
  • JKS 10-29-2025
  • Dividend Yield
  • AUPH N/A
  • JKS 5.98%
  • EPS Growth
  • AUPH N/A
  • JKS N/A
  • EPS
  • AUPH 0.42
  • JKS N/A
  • Revenue
  • AUPH $260,111,000.00
  • JKS $11,445,691,729.00
  • Revenue This Year
  • AUPH $16.92
  • JKS N/A
  • Revenue Next Year
  • AUPH $14.43
  • JKS $31.21
  • P/E Ratio
  • AUPH $30.31
  • JKS N/A
  • Revenue Growth
  • AUPH 25.59
  • JKS N/A
  • 52 Week Low
  • AUPH $6.43
  • JKS $13.42
  • 52 Week High
  • AUPH $12.87
  • JKS $37.36
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 68.02
  • JKS 60.36
  • Support Level
  • AUPH $12.06
  • JKS $23.60
  • Resistance Level
  • AUPH $12.82
  • JKS $25.88
  • Average True Range (ATR)
  • AUPH 0.37
  • JKS 1.05
  • MACD
  • AUPH -0.05
  • JKS 0.09
  • Stochastic Oscillator
  • AUPH 90.00
  • JKS 80.03

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.

Share on Social Networks: